Eli Lilly at Goldman Sachs Healthcare Conference 2026

Eli Lilly's Ken Custer said the obesity market is in its infancy despite millions of patients on these medicines. He noted billions could potentially benefit from the treatments. The scale of what remains to be accomplished surprised him most about the category's development.